Bacterial meningitis.
D000208:Acute Disease; D000293:Adolescent; D000328:Adult; D000367:Age Factors; D000667:Ampicillin / Q000494:pharmacology / Q000627:therapeutic use; D002140:California; D002648:Child; D002675:Child, Preschool; D002701:Chloramphenicol / Q000494:pharmacology / Q000627:therapeutic use; D006193:Haemophilus influenzae / Q000187:drug effects; D006801:Humans; D007093:Imidazoles / Q000627:therapeutic use; D007223:Infant; D008581:Meningitis / Q000188:drug therapy / Q000401:mortality; D008583:Meningitis, Haemophilus / Q000188:drug therapy / Q000401:mortality; D008585:Meningitis, Meningococcal / Q000188:drug therapy / Q000453:epidemiology / Q000401:mortality; D008586:Meningitis, Pneumococcal / Q000188:drug therapy / Q000401:mortality; D008875:Middle Aged; D009345:Neisseria meningitidis / Q000187:drug effects; D010400:Penicillin G / Q000494:pharmacology; D010406:Penicillins / Q000627:therapeutic use; D013296:Streptococcus pneumoniae / Q000187:drug effects; D013307:Streptomycin / Q000627:therapeutic use
D007093:Imidazoles; D010406:Penicillins; D002701:Chloramphenicol; D000667:Ampicillin; D010400:Penicillin G; D013307:Streptomycin